AMGN
Amgen Inc. Healthcare - Biotechnology Investor Relations →
Amgen Inc. (AMGN) closed at $337.60 as of 2026-06-19, trading 23.6% above its 200-week moving average of $273.21. The stock is currently moving closer to the line, down from 30.3% last week. The 14-week RSI sits at 39, indicating neutral momentum.
Trading volume is running at 2.0x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.90 ratio) is neutral — neither side is clearly dominating.
Over the past 2196 weeks of data, AMGN has crossed below its 200-week moving average 22 times. On average, these episodes lasted 16 weeks. Historically, investors who bought AMGN at the start of these episodes saw an average one-year return of +20.2%.
With a market cap of $182.2 billion, AMGN is a large-cap stock. The company generates a free cash flow yield of 4.1%. Return on equity stands at 101.3%, indicating strong profitability. The stock trades at 19.8x book value.
Over the past 33.5 years, a hypothetical investment of $100 in AMGN would have grown to $6489, compared to $3097 for the S&P 500. That represents an annualized return of 13.3% vs 10.8% for the index — confirming AMGN as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been declining at a -2.7% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: AMGN vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After AMGN Crosses Below the Line?
Across 21 historical episodes, buying AMGN when it crossed below its 200-week moving average produced an average return of +20.4% after 12 months (median +9.0%), compared to +10.1% for the S&P 500 over the same periods. 71% of those episodes were profitable after one year. After 24 months, the average return was +47.0% vs +22.8% for the index.
Each line shows $100 invested at the moment AMGN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices AMGN would reach each dislocation threshold.
Dislocation Price Levels
Prices where AMGN's Bean Score would hit each σ threshold. Valid until next earnings report: 2026-08-04.
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $316.06 | Unusually cheap — potential buy zone |
| Value | +1σ | $336.64 | Cheap vs. own history |
| Fair Value | +0σ | $360.07 | Historical mean behavior |
| Expensive | -1σ | $387.02 | Expensive vs. own history |
| Deep Expensive | -2σ | $418.32 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from AMGN's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
AMGN has crossed below its 200-week MA 22 times with an average 1-year return of +20.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 1984 | Apr 1985 | 49 | 42.7% | +35.6% | +429031.1% |
| Mar 1993 | Apr 1993 | 6 | 9.0% | +21.8% | +11999.6% |
| May 1993 | Oct 1993 | 20 | 19.9% | +29.8% | +11232.7% |
| Jan 1994 | May 1994 | 15 | 18.7% | +50.1% | +9507.5% |
| Jun 1994 | Jul 1994 | 7 | 9.2% | +56.3% | +8742.0% |
| Apr 2002 | Mar 2003 | 44 | 33.9% | +29.7% | +930.5% |
| Nov 2003 | Dec 2003 | 4 | 3.1% | +3.0% | +763.3% |
| Mar 2004 | Aug 2004 | 21 | 9.0% | +1.5% | +765.7% |
| Sep 2004 | Nov 2004 | 8 | 8.8% | +47.5% | +777.6% |
| Mar 2005 | Apr 2005 | 1 | 0.3% | +26.9% | +776.9% |
| Feb 2007 | Jul 2008 | 74 | 36.9% | -26.3% | +714.4% |
| Sep 2008 | Jul 2009 | 46 | 25.4% | -2.4% | +732.5% |
| Aug 2009 | Sep 2009 | 3 | 1.5% | -12.6% | +743.6% |
| Sep 2009 | Oct 2009 | 1 | 0.9% | -5.2% | +758.5% |
| Oct 2009 | Jan 2010 | 14 | 8.6% | +2.5% | +795.3% |
| Feb 2010 | Mar 2010 | 3 | 1.6% | -4.9% | +790.4% |
| May 2010 | Sep 2010 | 20 | 8.6% | +5.8% | +823.4% |
| Nov 2010 | Dec 2010 | 5 | 1.8% | +6.8% | +823.2% |
| Feb 2011 | Apr 2011 | 11 | 3.4% | +26.6% | +835.8% |
| Aug 2011 | Aug 2011 | 3 | 7.6% | +61.0% | +864.9% |
| May 2023 | Jun 2023 | 3 | 1.5% | +45.4% | +70.6% |
| Jul 2023 | Jul 2023 | 1 | 1.3% | +46.6% | +69.3% |
| Average | 16 | — | +20.2% | — |
Frequently Asked Questions
Is AMGN below its 200-week moving average?
No. Amgen Inc. (AMGN) is currently 23.6% above its 200-week moving average of $273.21. It would need to fall to $273.21 to cross below the line.
What is AMGN's 200-week moving average price?
Amgen Inc.'s 200-week moving average is $273.21 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when AMGN drops below its 200-week moving average?
AMGN has crossed below its 200-week moving average 22 times in our data. On average, buying at that moment produced a one-year return of +20.2%. These dips have historically been decent entry points. These episodes lasted 16 weeks on average.
Is AMGN a good value right now?
Here's what our data says about AMGN as of 2026-06-19: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 39. Free cash flow yield is 4.1%. Return on equity is 101.3%. Price-to-book is 19.8x. This is not a buy or sell recommendation — always do your own research.
How does AMGN compare to the S&P 500?
Over the past 33.5 years, $100 invested in AMGN would have grown to $6489, compared to $3097 for the S&P 500. That's 13.3% annualized vs 10.8% for the index. AMGN has outperformed the broader market over this period.
Does AMGN pay a dividend?
Yes. Amgen Inc. currently pays a dividend yield of 290.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-06-19